Equine influenza-A global perspective

Veterinary Microbiology

Volumn 167, Issue 1-2, 2013, Pages 205-214

  Cullinane, A ^a   Newton, J R ^b  

^a IRISH EQUINE CENTRE   (Ireland)

^b ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

Epidemiology; Equine influenza; Laboratory diagnosis; Management; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTITUSSIVE AGENT; BRONCHODILATING AGENT; IMMUNOSTIMULATING AGENT; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; LIVE VACCINE; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; PERAMIVIR; RECOMBINANT VACCINE; SUBUNIT VACCINE;

ANTIBODY RESPONSE; BACTERIAL INFECTION; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EQUINE INFLUENZA; EQUINE INFLUENZA VIRUS; GENETIC DRIFT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION SENSITIVITY; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A H3N8; LABORATORY DIAGNOSIS; NONHUMAN; PHYLOGENY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERODIAGNOSIS; SEROEPIDEMIOLOGY; VIRUS DIAGNOSIS; VIRUS EXCRETION; VIRUS PATHOGENESIS;

EQUIDAE;

EPIDEMIOLOGY; EQUINE INFLUENZA; LABORATORY DIAGNOSIS; MANAGEMENT; VACCINATION;

ANIMALS; DISEASE OUTBREAKS; HORSE DISEASES; HORSES; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION; WORLD HEALTH;

EID: 84889080547     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.03.029     Document Type: Review

References (95)

1. Abdel-Moneim A.S., Abdel-Ghany A.E., Shany S.A. Isolation and characterization of highly pathogenic avian influenza virus subtype H5N1 from donkeys. J. Biomed. Sci. 2010, 17:25.
2. Barquero N., Daly J.M., Newton J.R. Risk factors for influenza infection in vaccinated racehorses: lessons from an outbreak in Newmarket, UK in 2003. Vaccine 2007, 25:7520-7529.
3. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., MacRae S., Lewis N.S., Paillot R., Zanoni R., Meier H., Griffiths L.A., Daly J.M., Tiwari A., Chambers T.M., Newton J.R., Elton D.M. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet. Microbiol. 2009, 138:41-52.
4. Bryant N.A., Rash A.S., Woodward A.L., Medcalf E., Helwegen M., Wohlfender F., Cruz F., Herrmann C., Borchers K., Tiwari A., Chambers T.M., Newton J.R., Mumford J.A., Elton D.M. Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet. Microbiol. 2011, 147:19-27.
5. Burrows R., Denyer M., Goodridge D., Hamilton F. Field and laboratory studies of equine influenza viruses isolated in 1979. Vet. Rec. 1981, 109:353-356.
6. Burrows R., Goodridge D., Denyer M., Hutchings G., Frank C.J. Equine influenza infections in Great Britain, 1979. Vet. Rec. 1982, 110:494-497.
7. Chambers T.M., Shortridge K.F., Li P.H., Powell D.G., Watkins K.L. Rapid diagnosis of equine influenza by the Directigen FLU-A enzyme immunoassay. Vet. Rec. 1994, 135:275-279.
8. Chambers T.M., Quinlivan M., Sturgill T., Cullinane A., Horohov D.W., Zamarin D., Arkins S., Garcia-Sastre A., Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet. J. 2009, 41:87-92.
9. Cowled B., Ward M.P., Hamilton S., Garner G. The equine influenza epidemic in Australia: spatial and temporal descriptive analyses of a large propagating epidemic. Prev. Vet. Med. 2009, 92:60-70.
10. Crawford P.C., Dubovi E.J., Castleman W.L., Stephenson I., Gibbs E.P., Chen L., Smith C., Hill R.C., Ferro P., Pompey J., Bright R.A., Medina M.J., Johnson C.M., Olsen C.W., Cox N.J., Klimov A.I., Katz J.M., Donis R.O. Transmission of equine influenza virus to dogs. Science 2005, 310:482-485.
11. Cullinane A., Weld J., Osborne M., Nelly M., McBride C., Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings. Vet. J. 2001, 161:174-185.
12. Cullinane A., Elton D., Mumford J. Equine influenza - surveillance and control. Influenza Other Respi Viruses 2010, 4:339-344.
13. Daly J.M., Lai A.C., Binns M.M., Chambers T.M., Barrandeguy M., Mumford J.A. Antigenic and genetic evolution of equine H3N8 influenza A viruses. J. Gen. Virol. 1996, 77(Pt 4):661-671.
14. Daly J.M., Yates R.J., Browse G., Swann Z., Newton J.R., Jessett D., Davis-Poynter N., Mumford J.A. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines. Equine Vet. J. 2003, 35:458-462.
15. Daly J.M., Whitwell K.E., Miller J., Dowd G., Cardwell J.M., Smith K.C. Investigation of equine influenza cases exhibiting neurological disease: coincidence or association?. J. Comp. Pathol. 2006, 134:231-235.
16. Daly J.M., Blunden A.S., Macrae S., Miller J., Bowman S.J., Kolodziejek J., Nowotny N., Smith K.C. Transmission of equine influenza virus to English foxhounds. Emerg. Infect. Dis. 2008, 14:461-464.
17. Daly J.M., MacRae S., Newton J.R., Wattrang E., Elton D.M. Equine influenza: a review of an unpredictable virus. Vet. J. 2011, 189:7-14.
18. Edlund Toulemonde C., Daly J., Sindle T., Guigal P.M., Audonnet J.C., Minke J.M. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet. Rec. 2005, 156:367-371.
19. Foord A.J., Selleck P., Colling A., Klippel J., Middleton D., Heine H.G. Real-time RT-PCR for detection of equine influenza and evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8). Vet. Microbiol. 2009, 137:1-9.
20. Garner M.G., Cowled B., East I.J., Moloney B.J., Kung N.Y. Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza-a modelling approach. Prev. Vet. Med. 2011, 99:15-27.
21. Gildea S., Arkins S., Cullinane A. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus. Influenza Other Respi Viruses 2010, 4:363-372.
22. Gildea S., Arkins S., Cullinane A. Management and environmental factors involved in equine influenza outbreaks in Ireland 2007-2010. Equine Vet. J. 2011, 43:608-617.
23. Gildea S., Arkins S., Walsh C., Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings-a randomised blind study. Vaccine 2011, 29:9214-9223.
24. Gildea S., Arkins S., Walsh C., Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study. Vaccine 2011, 29:3917-3922.
25. Gildea S., Quinlivan M., Arkins S., Cullinane A. The molecular epidemiology of equine influenza in Ireland from 2007-2010 and its international significance. Equine Vet. J. 2012, 44:387-392.
26. Glass K., Wood J.L., Mumford J.A., Jesset D., Grenfell B.T. Modelling equine influenza 1: a stochastic model of within-yard epidemics. Epidemiol. Infect. 2002, 128:491-502.
27. Gross D.K., Hinchcliff K.W., French P.S., Goclan S.A., Lahmers K.K., Lauderdale M., Ellis J.A., Haines D.M., Slemons R.D., Morley P.S. Effect of moderate exercise on the severity of clinical signs associated with influenza virus infection in horses. Equine Vet. J. 1998, 30:489-497.
28. Guo Y., Wang M., Kawaoka Y., Gorman O., Ito T., Saito T., Webster R.G. Characterization of a new avian-like influenza A virus from horses in China. Virology 1992, 188:245-255.
29. Guthrie A.J., Stevens K.B., Bosman P.P. The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Rev. Sci. Tech. 1999, 18:179-185.
30. Hannant D., Mumford J.A., Jessett D.M. Duration of circulating antibody and immunity following infection with equine influenza virus. Vet. Rec. 1988, 122:125-128.
31. Heine H.G., Trinidad L., Selleck P., Lowther S. Rapid detection of highly pathogenic avian influenza H5N1 virus by TaqMan reverse transcriptase-polymerase chain reaction. Avian Dis. 2007, 51:370-372.
32. Heldens J.G., Kersten A.J., Weststrate M.W., van den Hoven R. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine. Vet. Q. 2001, 23:210-217.
33. Hinshaw V.S., Naeve C.W., Webster R.G., Douglas A., Skehel J.J., Bryans J. Analysis of antigenic variation in equine 2 influenza A viruses. Bull. World Health Organ. 1983, 61:153-158.
34. Kasel J.A., Couch R.B. Experimental infection in man and horses with influenza A viruses. Bull. World Health Organ. 1969, 41:447-452.
35. Kastner S.B., Haines D.M., Archer J., Townsend H.G. Investigations on the ability of clenbuterol hydrochloride to reduce clinical signs and inflammation associated with equine influenza A infection. Equine Vet. J. 1999, 31:160-168.
36. King E.L., Macdonald D. Report of the Board of Inquiry appointed by the Board of the National Horseracing Authority to conduct enquiry into the causes of the equine influenza which started in the Western cape in early December 2003 and spread to the Eastern Cape and Gauteng. Aust. Equine Vet. 2004, 23:139-142.
37. Kirkland P.D., Finlaison D.S., Crispe E., Hurt A.C. Influenza virus transmission from horses to dogs, Australia. Emerg. Infect. Dis. 2010, 16:699-702.
38. Kirkland P.D., Davis R.J., Wong D., Ryan D., Hart K., Corney B., Hewitson G., Cooper K., Biddle A., Eastwood S., Slattery S., Rayward D., Evers M., Wright T., Halpin K., Selleck P., Watson J. The first five days: field and laboratory investigations during the early stages of the equine influenza outbreak in Australia, 2007. Aust. Vet. J. 2011, 89(Suppl. 1):6-10.
39. Kirkland P.D., Davis R.J., Gu X., Frost M. Application of high-throughput systems for the rapid detection of DNA and RNA viruses during the Australian equine influenza outbreak. Aust. Vet. J. 2011, 89(Suppl. 1):38-39.
40. Lai A.C., Chambers T.M., Holland R.E., Morley P.S., Haines D.M., Townsend H.G., Barrandeguy M. Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch. Virol. 2001, 146:1063-1074.
41. Livesay G.J., O'Neill T., Hannant D., Yadav M.P., Mumford J.A. The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Vet. Rec. 1993, 133:515-519.
42. Lu Z., Chambers T.M., Boliar S., Branscum A.J., Sturgill T.L., Timoney P.J., Reedy S.E., Tudor L.R., Dubovi E.J., Vickers M.L., Sells S., Balasuriya U.B. Development and evaluation of one-step TaqMan real-time reverse transcription-PCR assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus. J. Clin. Microbiol. 2009, 47:3907-3913.
43. Miller W.C. Equine influenza. Further observations on the "Coughing" Outbreak, 1965. Vet. Rec. 1965, 77:455-456.
44. Miller W.C. The Epidemiology of Equine Influenza 1965, 125-128. W.A. Pool, John Wright & Sons, Bristol. 7th edition.
45. Morens D.M., Taubenberger J.K. Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respi Viruses 2010, 4:327-337.
46. Morley P.S., Gross D.K., French P.S., Goclan S.A., Lauderdale M. Exercise and influenza virus infections in horses. 8th International Conference on Equine Infectious Diseases 1998, 57-63.
47. Morley P.S., Townsend H.G., Bogdan J.R., Haines D.M. Risk factors for disease associated with influenza virus infections during three epidemics in horses. J. Am. Vet. Med. Assoc. 2000, 216:545-550.
48. Mumford J.A., Rossdale P.D. Virus and its relationship to the "poor performance" syndrome. Equine Vet. J. 1980, 12:3-9.
49. Mumford J.A., Hannant D., Jessett D.M. Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Equine Vet. J. 1990, 22:93-98.
50. Mumford J.A. The diagnosis and control of equine influenza. Proceedings American Association of Equine Practitioners 1990, 377-385.
51. Mumford J.A., Wood J. Establishing an acceptability threshold for equine influenza vaccines. Dev. Biol. Stand. 1992, 79:137-146.
52. Mumford J., Wood J. WHO/OIE meeting: consultation on newly emerging strains of equine influenza. 18-19 May 1992, Animal Health Trust, Newmarket, Suffolk, UK. Vaccine 1993, 11:1172-1175.
53. Mumford J.A., Jessett D., Dunleavy U., Wood J., Hannant D., Sundquist B., Cook R.F. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 1994, 12:857-863.
54. Mumford J.A., Wilson H., Hannant D., Jessett D.M. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol. Infect. 1994, 112:421-437.
55. Nelson K.M., Schram B.R., McGregor M.W., Sheoran A.S., Olsen C.W., Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 1998, 16:1306-1313.
56. Newton J.R., Verheyen K., Wood J.L., Yates P.J., Mumford J.A. Equine influenza in the United Kingdom in 1998. Vet. Rec. 1999, 145:449-452.
57. Newton J.R., Townsend H.G., Wood J.L., Sinclair R., Hannant D., Mumford J.A. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet. J. 2000, 32:65-74.
58. Newton J.R., Lakhani K.H., Wood J.L., Baker D.J. Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine. Prev. Vet. Med. 2000, 46:129-141.
59. Newton J.R., Texier M.J., Shepard M.C. Modifying likely protection from equine influenza vaccination by varying dosage intervals within the Jockey Club Rules of Racing. Equine Vet. Educ. 2005, 17:314-318.
60. Newton J.R., Daly J.M., Spencer L., Mumford J.A. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet. Rec. 2006, 158:185-192.
61. Newton R., Cooke A., Elton D., Bryant N., Rash A., Bowman S., Blunden T., Miller J., Hammond T.A., Camm I., Day M. Canine influenza virus: cross-species transmission from horses. Vet. Rec. 2007, 161:142-143.
62. Paillot R., Hannant D., Kydd J.H., Daly J.M. Vaccination against equine influenza: quid novi?. Vaccine 2006, 24:4047-4061.
63. Paillot R., Kydd J.H., MacRae S., Minke J.M., Hannant D., Daly J.M. New assays to measure equine influenza virus-specific Type 1 immunity in horses. Vaccine 2007, 25:7385-7398.
64. Park A.W., Wood J.L., Newton J.R., Daly J., Mumford J.A., Grenfell B.T. Optimising vaccination strategies in equine influenza. Vaccine 2003, 21:2862-2870.
65. Park A.W., Wood J.L., Daly J.M., Newton J.R., Glass K., Henley W., Mumford J.A., Grenfell B.T. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population. Proc. Biol. Sci. 2004, 271:1547-1555.
66. Patterson-Kane J.C., Carrick J.B., Axon J.E., Wilkie I., Begg A.P. The pathology of bronchointerstitial pneumonia in young foals associated with the first outbreak of equine influenza in Australia. Equine Vet. J. 2008, 40:199-203.
67. Powell D.G., Watkins K.L., Li P.H., Shortridge K.F. Outbreak of equine influenza among horses in Hong Kong during 1992. Vet. Rec. 1995, 136:531-536.
68. Qi T., Guo W., Huang W.Q., Li H.M., Zhao L.P., Dai L.L., He N., Hao X.F., Xiang W.H. Genetic evolution of equine influenza viruses isolated in China. Arch. Virol. 2010, 155:1425-1432.
69. Quinlivan M., Cullinane A., Nelly M., Van Maanen K., Heldens J., Arkins S. Comparison of sensitivities of virus isolation, antigen detection, and nucleic acid amplification for detection of equine influenza virus. J. Clin. Microbiol. 2004, 42:759-763.
70. Quinlivan M., Dempsey E., Ryan F., Arkins S., Cullinane A. Real-time reverse transcription PCR for detection and quantitative analysis of equine influenza virus. J. Clin. Microbiol. 2005, 43:5055-5057.
71. Quinlivan M., Zamarin D., Garcia-Sastre A., Cullinane A., Chambers T., Palese P. Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 2005, 79:8431-8439.
72. Quinlivan M., Nelly M., Prendergast M., Breathnach C., Horohov D., Arkins S., Chiang Y.W., Chu H.J., Ng T., Cullinane A. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. Vaccine 2007, 25:7056-7064.
73. Read A.J., Arzey K.E., Finlaison D.S., Gu X., Davis R.J., Ritchie L., Kirkland P.D. A prospective longitudinal study of naturally infected horses to evaluate the performance characteristics of rapid diagnostic tests for equine influenza virus. Vet. Microbiol. 2012, 156:246-255.
74. Shi W., Lei F., Zhu C., Sievers F., Higgins D.G. A complete analysis of HA and NA genes of influenza A viruses. PLoS ONE 2010, 5:e14454.
75. Smith K.C., Daly J.M., Blunden A.S., Laurence C.J. Canine influenza virus. Vet. Rec. 2005, 157:599.
76. Townsend H.G., Penner S.J., Watts T.C., Cook A., Bogdan J., Haines D.M., Griffin S., Chambers T., Holland R.E., Whitaker-Dowling P., Youngner J.S., Sebring R.W. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet. J. 2001, 33:637-643.
77. Tu J., Zhou H., Jiang T., Li C., Zhang A., Guo X., Zou W., Chen H., Jin M. Isolation and molecular characterization of equine H3N8 influenza viruses from pigs in China. Arch. Virol. 2009, 154:887-890.
78. van Maanen C., Bruin G., de Boer-Luijtze E., Smolders G., de Boer G.F. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. Vet. Q. 1992, 14:13-17.
79. van Maanen C., Cullinane A. Equine influenza virus infections: an update. Vet. Q. 2002, 24:79-94.
80. Van Oirschot J.T., Bruin G., de Boer-Luytze E., Smolders G. Maternal antibodies against equine influenza virus in foals and their interference with vaccination. Zentralbl Veterinarmed B 1991, 38:391-396.
81. Virmani N., Bera B.C., Singh B.K., Shanmugasundaram K., Gulati B.R., Barua S., Vaid R.K., Gupta A.K., Singh R.K. Equine influenza outbreak in India (2008-09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Vet. Microbiol. 2010, 143:224-237.
82. Watson J., Halpin K., Selleck P., Axell A., Bruce K., Hansson E., Hammond J., Daniels P., Jeggo M. Isolation and characterisation of an H3N8 equine influenza virus in Australia, 2007. Aust. Vet. J. 2011, 89(Suppl. 1):35-37.
83. Wattrang E., Jessett D.M., Yates P., Fuxler L., Hannant D. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. Viral Immunol. 2003, 16:57-67.
84. Webster R.G., Guo Y.J. New influenza virus in horses. Nature 1991, 351:527.
85. Webster R.G. Are equine 1 influenza viruses still present in horses?. Equine Vet. J. 1993, 25:537-538.
86. Willoughby R., Ecker G., McKee S., Riddolls L., Vernaillen C., Dubovi E., Lein D., Mahony J.B., Chernesky M., Nagy E., et al. The effects of equine rhinovirus, influenza virus and herpesvirus infection on tracheal clearance rate in horses. Can. J. Vet. Res. 1992, 56:115-121.
87. Wilson W.D. Equine influenza. Vet. Clin. North Am. Equine Pract. 1993, 9:257-282.
88. Wood, J.L.N., 1991. A review of the history and epidemiology and a description of recent outbreak. MSc Dissertation. University of London, London.
89. Yadav M.P., Uppal P.K., Mumford J.A. Physico-chemical and biological characterization of A/Equi-2 virus isolated from 1987 equine influenza epidemic in India. Int. J. Anim. Sci. 1993, 8:93-98.
90. Yamanaka T., Niwa H., Tsujimura K., Kondo T., Matsumura T. Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J. Vet. Med. Sci. 2008, 70:623-625.
91. Yamanaka T., Tsujimura K., Kondo T., Matsumura T. Evaluation of antigen detection kits for diagnosis of equine influenza. J. Vet. Med. Sci. 2008, 70:189-192.
92. Yamanaka T., Nemoto M., Tsujimura K., Kondo T., Matsumura T. Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses. Vet. Microbiol. 2009, 139:351-355.
93. Yamanaka T., Nemoto M., Bannai H., Tsujimura K., Kondo T., Matsumura T., Muranaka M., Ueno T., Kinoshita Y., Niwa H., Hidari K.I., Suzuki T. No evidence of horizontal infection in horses kept in close contact with dogs experimentally infected with canine influenza A virus (H3N8). Acta Vet. Scand. 2012, 54:25.
94. Yamanaka T., Bannai H., Nemoto M., Tsujimura K., Kondo T., Muranaka M., Hobo S., Minamijima Y.H., Yamada M., Matsumura T. Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza. Vet. J. 2012, 193:358-362.
95. Yondon M., Heil G.L., Burks J.P., Zayat B., Waltzek T.B., Jamiyan B.O., McKenzie P.P., Krueger W.S., Friary J.A., Gray G.C. Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza Other Respi Viruses 2013, (Epub ahead of print). 10.1111/irv.12069.